John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,000 shares at $30.00 ($301K) on 2016-07-26, disclosed to the SEC on 2016-07-28.
Scheduled sale ($301k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 813 | $24K | 8.1% |
| 2 | $30.15 | 9,187 | $277K | 91.9% |
| Total | $30.14 avg | 10,000 | $301K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |